Tue, Oct 21, 2014, 5:51 AM EDT - U.S. Markets open in 3 hrs 39 mins


% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • jsblvbjb jsblvbjb Jun 7, 2013 12:21 PM Flag

    The reality...

    1. 3 to 13 is a tremendous move in 12 months.
    2. Russell inclusion is a lock barring an unexpected event.
    3. Russell's effect on the current share price will be substantial (it is for all stocks that get included or dumped).
    4. Phase 3 results are imminent and will have a major effect on the current share price.

    If you took my advice and bought at 6 dollars a share, congratulations! My second play would be to sell half if you are risk-averse and let the rest ride for a potential move to 24 post phase 3 news. If you have tremendous guts, then hold with the entire investment and profit in a best-case scenario of "expected" Arikace superiority over Tobi. The fact that Russell inclusion and Phase 3 are potentially going to be simultaneous events adds another wrinkle to the trade. Meanwhile shorts have positioned themselves for the usual downdraft that follows major biotech moves, but I predict they are making a big mistake, and a squeeze is highly favorable due to the coming inclusion and phase 3 one-two punch. FWIW, I am a long term investor with INSM, so short term moves are simply fun to predict, but I do not participate by day trading or by trying to capture short term gains. Go INSM!!!
    God bless,

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
13.52+0.23(+1.73%)Oct 20 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
NYSEMon, Oct 20, 2014 4:03 PM EDT
NCR Corp.
NYSEMon, Oct 20, 2014 4:02 PM EDT